Opko Health (OPK) Other financing activities (2014 - 2024)

Opko Health (OPK) reported Other financing activities of $13.4 million for Q3 2024, up 56.33% quarter-over-quarter from $8.6 million in Q2 2024.

Opko Health (OPK) Other financing activities (2014 - 2024) Analysis & Trends

Opko Health has reported Other financing activities for 4 years, with the latest figure at $13.4 million in Q3 2024.

For the quarter ending Q3 2024, Other financing activities changed N/A year-over-year to $13.4 million; the trailing twelve-month figure through Sep 2025 stood at $13.4 million (down 56.13% YoY), and the FY2024 full-year result was $13.4 million, changed N/A from the prior year.
Other financing activities for Q3 2024 stood at $13.4 million, up from $8.6 million in the prior quarter.
The five-year high for Other financing activities was $13.4 million in Q3 2024, with the low at $8.6 million in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	Opko Health	1.09 Bn	747.11 Mn	45.76 Mn

Download Data